Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance. [electronic resource]
Producer: 20030430Description: 1466-71 p. digitalISSN:- 0732-183X
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- CD55 Antigens -- metabolism
- CD59 Antigens -- metabolism
- Complement System Proteins -- drug effects
- Drug Resistance, Neoplasm
- Flow Cytometry
- Gene Expression Regulation, Neoplastic
- Humans
- Immunoblotting
- Leukemia, Lymphocytic, Chronic, B-Cell -- immunology
- Multicenter Studies as Topic
- Myeloid Cell Leukemia Sequence 1 Protein
- Neoplasm Proteins -- metabolism
- Proto-Oncogene Proteins -- metabolism
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Rituximab
- Treatment Outcome
- bcl-2-Associated X Protein
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.